Literature DB >> 27246830

miR-182-5p Induced by STAT3 Activation Promotes Glioma Tumorigenesis.

Jianfei Xue1, Aidong Zhou1, Yamei Wu2, Saint-Aaron Morris1, Kangyu Lin1, Samirkumar Amin3, Roeland Verhaak3, Gregory Fuller4, Keping Xie5, Amy B Heimberger1, Suyun Huang6.   

Abstract

Malignant glioma is an often fatal type of cancer. Aberrant activation of STAT3 leads to glioma tumorigenesis. STAT3-induced transcription of protein-coding genes has been extensively studied; however, little is known about STAT3-regulated miRNA gene transcription in glioma tumorigenesis. In this study, we found that abnormal activation or decreased expression of STAT3 promotes or inhibits the expression of miR-182-5p, respectively. Bioinformatics analyses determined that tumor suppressor protocadherin-8 (PCDH8) is a candidate target gene of miR-182-5p. miR-182-5p negatively regulated PCDH8 expression by directly targeting its 3'-untranslated region. PCDH8 knockdown induced the proliferative and invasive capacities of glioma cells. Silencing of PCDH8 or miR-182-5p mimics could reverse the inhibitory effect of WP1066, a STAT3 inhibitor, or STAT3 knockdown in vitro and in vivo on glioma progression. Clinically, expression levels of PCDH8 were inversely correlated with those of p-STAT3 or miR-182-5p in glioblastoma tissues. These findings reveal that the STAT3/miR-182-5p/PCDH8 axis has a critical role in glioma tumorigenesis and that targeting the axis may provide a new therapeutic approach for human glioma. Cancer Res; 76(14); 4293-304. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27246830      PMCID: PMC5033679          DOI: 10.1158/0008-5472.CAN-15-3073

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  44 in total

Review 1.  Signaling-mediated regulation of MicroRNA processing.

Authors:  Jia Shen; Mien-Chie Hung
Journal:  Cancer Res       Date:  2015-02-06       Impact factor: 12.701

2.  Stat3-mediated activation of microRNA-23a suppresses gluconeogenesis in hepatocellular carcinoma by down-regulating glucose-6-phosphatase and peroxisome proliferator-activated receptor gamma, coactivator 1 alpha.

Authors:  Bo Wang; Shu-Hao Hsu; Wendy Frankel; Kalpana Ghoshal; Samson T Jacob
Journal:  Hepatology       Date:  2012-06-05       Impact factor: 17.425

3.  Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma.

Authors:  Violetta V Leshchenko; Pei-Yu Kuo; Rita Shaknovich; David T Yang; Tobias Gellen; Adam Petrich; Yiting Yu; Yvonne Remache; Marc A Weniger; Sarwish Rafiq; K Stephen Suh; Andre Goy; Wyndham Wilson; Amit Verma; Ira Braunschweig; Natarajan Muthusamy; Brad S Kahl; John C Byrd; Adrian Wiestner; Ari Melnick; Samir Parekh
Journal:  Blood       Date:  2010-04-28       Impact factor: 22.113

4.  Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer metastasis.

Authors:  Jianfei Xue; Xia Lin; Wen-Tai Chiu; Yao-Hui Chen; Guanzhen Yu; Mingguang Liu; Xin-Hua Feng; Raymond Sawaya; René H Medema; Mien-Chie Hung; Suyun Huang
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

5.  Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma.

Authors:  M R Morris; C J Ricketts; D Gentle; F McRonald; N Carli; H Khalili; M Brown; T Kishida; M Yao; R E Banks; N Clarke; F Latif; E R Maher
Journal:  Oncogene       Date:  2010-12-06       Impact factor: 9.867

Review 6.  MicroRNAs, cancer and cancer stem cells.

Authors:  Amy L Zimmerman; Shiyong Wu
Journal:  Cancer Lett       Date:  2010-10-20       Impact factor: 8.679

Review 7.  Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: clinical implications.

Authors:  Suyun Huang
Journal:  Clin Cancer Res       Date:  2007-03-01       Impact factor: 12.531

8.  microRNA-148a is a prognostic oncomiR that targets MIG6 and BIM to regulate EGFR and apoptosis in glioblastoma.

Authors:  Jungeun Kim; Ying Zhang; Michael Skalski; Josie Hayes; Benjamin Kefas; David Schiff; Benjamin Purow; Sarah Parsons; Sean Lawler; Roger Abounader
Journal:  Cancer Res       Date:  2014-01-14       Impact factor: 12.701

9.  miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma.

Authors:  Jun Wei; Fei Wang; Ling-Yuan Kong; Shuo Xu; Tiffany Doucette; Sherise D Ferguson; Yuhui Yang; Kayla McEnery; Krishan Jethwa; Olsi Gjyshi; Wei Qiao; Nicholas B Levine; Frederick F Lang; Ganesh Rao; Gregory N Fuller; George A Calin; Amy B Heimberger
Journal:  Cancer Res       Date:  2013-05-01       Impact factor: 12.701

10.  miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma.

Authors:  Fotini M Kouri; Lisa A Hurley; Weston L Daniel; Emily S Day; Youjia Hua; Liangliang Hao; Chian-Yu Peng; Timothy J Merkel; Markus A Queisser; Carissa Ritner; Hailei Zhang; C David James; Jacob I Sznajder; Lynda Chin; David A Giljohann; John A Kessler; Marcus E Peter; Chad A Mirkin; Alexander H Stegh
Journal:  Genes Dev       Date:  2015-04-01       Impact factor: 11.361

View more
  35 in total

1.  MiR-424 functions as a tumor suppressor in glioma cells and is down-regulated by DNA methylation.

Authors:  Chen Jin; Minhong Li; Yian Ouyang; Zhigang Tan; Yugang Jiang
Journal:  J Neurooncol       Date:  2017-05-15       Impact factor: 4.130

2.  Geraniin suppresses tumor cell growth and triggers apoptosis in human glioma via inhibition of STAT3 signaling.

Authors:  Zhong Ren; Wenshuang Zou; Junfeng Cui; Luping Liu; Yang Qing; Yongmei Li
Journal:  Cytotechnology       Date:  2017-04-03       Impact factor: 2.058

3.  LncRNA LINC01094 contributes to glioma progression by modulating miR-224-5p/CHSY1 axis.

Authors:  Luotong Liu; Qian Xu; Yu Xiong; Huajiang Deng; Jie Zhou
Journal:  Hum Cell       Date:  2021-10-30       Impact factor: 4.174

4.  Long non-coding RNA LINC01018 inhibits human glioma cell proliferation and metastasis by directly targeting miRNA-182-5p.

Authors:  Hu Su; Zhao Hailin; Luo Dongdong; Yin Jiang; Huang Shuncheng; Zhang Shun; Li Dan; Peng Biao
Journal:  J Neurooncol       Date:  2022-09-12       Impact factor: 4.506

5.  The role of miRNAs as a predictor of multicentricity in breast cancer.

Authors:  Huseyin Akbulut; Yeliz Emine Ersoy; Ender Coskunpinar; Zuhal Gucin; Seyma Yildiz; Fatma Umit Malya; Burcu Hasturk; Mahmut Muslumanoglu
Journal:  Mol Biol Rep       Date:  2019-02-01       Impact factor: 2.316

6.  Downregulation of miR-196-5p Induced by Hypoxia Drives Tumorigenesis and Metastasis in Hepatocellular Carcinoma.

Authors:  Hao Zheng; Feng-Rui Bi; Yuan Yang; Yong-Gang Hong; Jun-Sheng Ni; Long Ma; Ming-Hua Liu; Li-Qiang Hao; Wei-Ping Zhou; Li-Hua Song; Hong-Li Yan
Journal:  Horm Cancer       Date:  2019-11-12       Impact factor: 3.869

7.  LINC02308 promotes the progression of glioma through activating mTOR/AKT-signaling pathway by targeting miR-30e-3p/TM4SF1 axis.

Authors:  Xianfeng Gao; Xiaoya Wang; Huaiqiang He; Yang Cao
Journal:  Cell Biol Toxicol       Date:  2021-05-04       Impact factor: 6.691

Review 8.  Sensational MicroRNAs: Neurosensory Roles of the MicroRNA-183 Family.

Authors:  Samantha A Banks; Marsha L Pierce; Garrett A Soukup
Journal:  Mol Neurobiol       Date:  2019-07-29       Impact factor: 5.682

9.  LncRNA TCONS_00004099-derived microRNA regulates oncogenesis through PTPRF in gliomas.

Authors:  Yuhao Wang; Aijun Shan; Zhiwei Zhou; Wenpeng Li; Lin Xie; Bo Du; Bingxi Lei
Journal:  Ann Transl Med       Date:  2021-06

10.  CircMTO1 inhibits ox-LDL-stimulated vascular smooth muscle cell proliferation and migration via regulating the miR-182-5p/RASA1 axis.

Authors:  Ningning Ji; Yu Wang; Xinyan Gong; Shimao Ni; Hui Zhang
Journal:  Mol Med       Date:  2021-07-08       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.